Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 0.01%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for TODOS MEDICAL LTD. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv-Yafo, Israel.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
6 buys9 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| COMMISSIONG GERALDtrack record | Buy | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | conv 69 |
| SEC |
| COMMISSIONG GERALDtrack record | Buy | $30K | conv 84Unusual sizeFirst in 12mo | SEC |
| COMMISSIONG GERALDtrack record | Buy | $31.5K | conv 97Unusual sizeFirst in 12mo | SEC |
| Strategic Investment Holdings, LLC | Sell | $5.9K | SEC |
| Strategic Investment Holdings, LLC | Sell | $6K | SEC |
| Strategic Investment Holdings, LLC | Sell | $137.9K | Unusual size | SEC |
| Strategic Investment Holdings, LLC | Sell | $5K | SEC |
| Strategic Investment Holdings, LLC | Buy | $1M | conv 41 | SEC |
| Strategic Investment Holdings, LLC | Sell | $5K | SEC |
| Strategic Investment Holdings, LLC | Buy | $1.5M | conv 56 | SEC |
| Strategic Investment Holdings, LLC | Sell | $7.5K | SEC |
| Strategic Investment Holdings, LLC | Sell | $7.5K | SEC |
| Strategic Investment Holdings, LLC | Buy | $1M | conv 56First in 12mo | SEC |
| Strategic Investment Holdings, LLC | Sell | $92K | Unusual size | SEC |
| Strategic Investment Holdings, LLC | Sell | $6K | SEC |